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Abstact
Background: Gamma amino butyric acid (GABA), the principal inhibitory neurotransmitter in the cerebral cortex,
maintains the inhibitory tones that counter balances neuronal excitation. When this balance is perturbed, seizures
may ensue.
Methods: In the present study, alterations of the general GABA, GABAA and GABAB receptors in the cerebral cortex
of the epileptic rat and the therapeutic application of Bacopa monnieri were investigated.
Results: Scatchard analysis of [
3H]GABA, [
3H]bicuculline and [
3H]baclofen in the cerebral cortex of the epileptic rat
showed significant decrease in Bmax (P < 0.001) compared to control. Real Time PCR amplification of GABA
receptor subunits such as GABAAά1, GABAAg, GABAAδ, GABAB and GAD where down regulated (P < 0.001) in
epileptic rats. GABAAά5 subunit and Cyclic AMP responsible element binding protein were up regulated. Confocal
imaging study confirmed the decreased GABA receptors in epileptic rats. Epileptic rats have deficit in radial arm
and Y maze performance.
Conclusions: Bacopa monnieri and Bacoside-A treatment reverses epilepsy associated changes to near control
suggesting that decreased GABA receptors in the cerebral cortex have an important role in epileptic occurrence;
Bacopa monnieri and Bacoside-A have therapeutic application in epilepsy management.
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Background
GABA is formed within GABAergic axon terminals and
released into the synapse, where it acts at one of two
types of receptor GABAA which controls chloride entry
into the cell, and GABAB, which increases potassium
conductance, decreases calcium entry, and inhibits the
presynaptic release of other neurotransmitters [1,2].
Temporal lobe epilepsy (TLE) is considered the most
common epileptic syndrome and it is estimated that
approximately 80% of patients with partial seizures have
temporal lobe epilepsy [3]. The effect of pilocarpine
treatment, which is characterized by generalized convul-
sive status epilepticus in rodents, well represents the
characteristic neuropathological findings in the brain
regions of the patients with TLE epilepsy [4]. Imbalance
between excitatory and inhibitory synaptic transmission
in key brain areas are implicated in the pathophysiology
of TLE, in which there is a decrease in the GABA
mediated inhibition. TLE seizures reflect excess excita-
tion, which result from local inhibitory circuit dysfunc-
tion. The existence of multiple GABAA receptor
subtypes differing in subunit composition, localization
and functional properties underlies their role for fine-
tuning of neuronal circuits and genesis of network oscil-
lations. The differential regulation of GABAA receptor
subtypes represents a major facet of homeostatic synap-
tic plasticity and contributes to the excitation/inhibition
(E/I) balance under physiological conditions and upon
pathological challenges [5]. Glutamate decarboxylase
(GAD) is an enzyme that catalyzes the decarboxylation
of glutamate to GABA. GAD is the rate limiting enzyme
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GABAergic activity [6]. cAMP response element-binding
protein (CREB) is a transcription factor that has been
implicated in the activation of protein synthesis required
for long-term memory and seizure formation [7]. Find-
ings shows that GABAB receptor subunit gene expres-
sion in hippocampal neurons is mediated through the
CREB by binding to unique cAMP response elements in
the alternative promoter regions [8]. Radial arm maze is
a means to examine the neural systems that are involved
in memory and the influence of pharmacological com-
pounds on memory [9,10]. Y-maze used to evaluate the
spatial learning by the different animal models of the
rats [11]
The potential for antiepileptic drugs to negatively
impact cognitive abilities is of significant concern
b e c a u s et h e ya r et h em a j o rt h e r a p e u t i cm o d a l i t yf o r
control of seizures. An increased risk for cognitive defi-
cits has been noted in patients with temporal lobe sei-
zures. Moreover, many of the anticonvulsant drugs
presently used for treating epilepsy cannot prevent neu-
rodegeneration but rather contribute towards these cog-
nitive deficits [12,13]. The available anti-epileptic drugs
are not curative since they mostly treat the symptoms of
the disease and render little help to alleviate its cause.
This has instilled a renewed interest in traditionally
used herbal drugs and formulations, which are safe in
prolonged usage for the management of epilepsy.
Bacopa monnieri is well known for its neuropharmaco-
logical effects. It is currently recognized as being effective
in the treatment of mental illness and epilepsy [14].
Treatments with Bacopa monnieri extract [15] have
enhanced learning ability. Cognition-facilitating effect
was due to two active saponins, bacosides A and B pre-
sent in the ethanol extract [16]. These active principles,
apart from facilitating learning and memory in normal
rats, inhibited the amnesic effects of scopolamine, elec-
troshock and immobilization stress. Crude plant extract
or bacosides have also shown anxiolytic effects, antide-
pressant activity, anticonvulsive action and antioxidant
activity [17]. In vitro studies using Bacopa monnieri have
been found to inhibit free radical formation and DNA
damage in a dose dependent manner [14]. But so far
there are very few studies reporting the role of Bacopa
monnieri treatment on the functional regulation of
GABA receptors. In this study, we investigated the anti-
epileptic effect of Bacopa monnieri on the GABAergic
receptor binding, gene expression in the cerebral cortex
and spatial learning and memory in epileptic rats.
Methods
Chemicals Used in the Study
Biochemicals used in the present study were purchased
from Sigma Chemical Co., St. Louis, USA. All other
reagents were of analytical grade purchased locally [
3H]
GABA [
3H]bicuculline and [
3H]baclofen were purchased
from NEN life sciences products Inc., Boston, U.S.A.
Animals
Adult Wistar rats of 250-300 g body weight purchased
from Amrita Institue of Medical Sciences, Cochin and
Kerala Agriculture University, were used for all experi-
ments. They were housed in separate cages under 12
hrs light and 12 hrs dark periods and were maintained
on standard food pellets and water adlibitum. All ani-
mal care and procedures were taken in accordance with
the Institutional, National Institute of Health and
CPESCA guidelines.
Plant material and Preparation of extract
Specimen of Bacopa monnieri (L.) Pennel were collected
from Cochin University area and were taxonomically
identified and authenticated by Mr. K. P. Joseph, Head,
Dept. of Botany (retd.), St. Peter’s College, Kollenchery
and voucher specimens was deposited at a herbarium
(No: MNCB3) of Centre for Neuroscience, Cochin Uni-
versity of Science and Technology, Cochin, Kerala,
India. Fresh, whole Bacopa monnieri plant were col-
lected and washed. Leaves, roots and stems of Bacopa
monnieri plant were cut into small pieces and dried in
shade. 100 g fresh plant dried in shade yielded approxi-
mately 15 g powder. Homogenate was extracted at
required concentration (300 mg fresh plant/kg body
weight) by dissolving 450 mg of dried powder in 80 ml
distilled water and used for the study [18,19].
Induction of Epilepsy in adult rats
Adult male Wistar rats, weighing 250 to 300 g, were
housed for 1 to 2 weeks before experiments were per-
formed. Epilepsy was induced by injecting rats with pilo-
carpine (350 mg/kg body weight i.p.), preceded by 30
min with atropine (1 mg/kg body weight i.p.) to reduce
peripheral pilocarpine effects. Within 20 to 40 min after
the pilocarpine injection, essentially all the animals
developed status epilepticus (SE). Control animals were
given saline injection. Behavioural observation continued
for 5 hrs after pilocarpine injection. SE was allowed to
continue for 1 hr and then control and experimental
animals were treated with diazepam (4 mg/kg body
weight i.p.). Animals recovered from this initial treat-
ment within 2 to 3 days and were observed for the next
3 weeks. 24 days after pilocarpine treatment, the rats
were continuously video monitored for 72 hrs. The
behaviour and seizures were captured with a CCD cam-
era and a Pinnacle PCTV capturing software card. One
trained technician, blind to all experimental conditions,
viewed all videos. Seizure activity was rated according to
Racine Scale [20]. Seizures were assessed by viewing
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running, forelimb clonus and/or rearing) during obser-
vation of the videos. Experimental rats which showed
recurrent seizures were used for the further experi-
ments. Experimental rats were divided into five groups:
1) Control (C), 2) Epileptic (E), 3) Epileptic rats treated
with Bacopa monnieri (E+B), 4) Epileptic rats treated
with bacoside-A (E+D), 5) Epileptic rats treated with
carbamazepine (E+C). Bacopa monnieri treated rats
were given extract of Bacopa monnieri orally in the
dosage 300 mg/kg body weight/day for 15 days. Carba-
mazepine- a standard drug used for the treatment of
epilepsy was given orally in the dosage 150 mg/kg body
weight/day for 15 days. Bacoside-A was given orally in
t h ed o s a g e1 5 0m g / k gb o d yw e i g h t / d a yf o r1 5d a y s .
After the treatment the rats were sacrificed and the tis-
sues were stored in -80°C.
Protein Determination
Protein was measured by the method of Lowry et al [21]
using bovine serum albumin as standard. The intensity
of the purple blue colour formed was proportional to
the amount of protein, which was read in a spectrophot-
ometer at 660 nm.
GABA Receptor Binding Assay
[
3H]GABA binding to GABA, [
3H]bicuculline to GABAA
and [
3H]baclofen binding to GABAB receptors were
assayed in triton x-100 treated synaptic membranes
according to the procedure of Kurioka et al [22]. Crude
synaptic membrane was prepared using sodium-free 10
mM Tris buffer (P
H7.4). Each assay tube contained a
protein concentration of 100 mg. In saturation binding
experiments, 5-40 nM of [
3H] GABA incubated with
and without excess of unlabelled GABA (100 μM). The
incubation was continued for 20 min at 40°C and termi-
nated by centrifugation at 35000 xg for 20 min. [
3H]
GABA in the pellet was determined by liquid scintilla-
tion spectrometry. Specific binding was determined by
subtracting non-specific binding from the total binding.
Real-Time Polymerase Chain Reaction
Total RNA was isolated from the cerebral cortex of con-
trol and experimental rats using Tri reagent. RNA was
reverse transcribed using ABI PRISM cDNA Archive kit.
20 μl of the reaction mixture contained 0.2 μgt o t a l
RNA, 10X RT buffer, 25X dNTP mixture, 10X Random
primers, MultiScribe RT (50 U/μl) and RNAase free
water. The reactions were carried out at 25°C for 10
minutes and 37°C for 2 hours using an Eppendorf Per-
sonal Cycler. Real-Time PCR assays were performed
using specific primer and fluorescently labeled Taq
p r o b ei na nA B I7 3 0 0R e a l - T i m eP C Ri n s t r u m e n t
(Applied Biosystems). The TaqMan reaction mixture of
20 μl contained 25 ng of total RNA-derived cDNAs, 200
nM each of the forward primer, reverse primer and
TaqMan probe for specific gene, endogenous control, b-
actin and 12.5 μl of TaqMan 2X Universal PCR Master-
mix. The thermocycling profile conditions used were:
50°C - 2 minutes - Activation; 95°C - 10 minutes -
Initial Denaturation; followed by 40 cycles of 95°C - 15
seconds - Denaturation and 60°C-1 minute - Annealing.
The ΔΔCT method of relative quantification was used
to determine the fold change in expression. This was
done by first normalizing the resulting threshold cycle
(CT) values of the target mRNAs to the CT values of
the internal control b-actin in the same samples (ΔCT =
CTTarget -C T b-actin). It was further normalized with the
control (ΔΔCT = ΔCT - CT Control). The fold change in
expression was then obtained as (2
-ΔΔCT) and expressed
as log 2
-ΔΔCT.
The sequences of the probe were
GABAAά1 :- ATTTGGGAGCTATGCTTATACAAGA
GABAAά5 :- CAGCACCAGCACAGGTGAATATACA
GABAAg3 :- GCATGCTCGGTCCAGGAGGGTGGAA
GABAAδ :- CCGCACCATGGCGCCAGAGCAATGA
GAD65:- AGTCATTACAAATCT TGCCC
The sequences of the primers were
GABAAά15 ’ ACA AGA AGC CAG AGA ACA AGC CAG 3’
5’ GAG GTC TAC TGG TAA GCT CTA CCA 3’
GABAAά55 ’ TGA GAT GGC CAC ATC AGA AGC AGT 3’
5’ TCA TGG GAG GCT GGA GTT TAG TTC 3’
GABAAg35 ’ CAG AGA CAG GAA GCT GAA AAG CAA 3’
5’ CGA AGT GAT TAT ATT GGA CTA AGC 3’
GABAAδ 5’ TGT GAG CAA CCG GAA ACC AAG CAA-3’
5’ CGT GTG ATT CAG CGA ATA AGA CCC-3’
GAD65 5’GCCCAGGCTCATCGCATTCA-3’
5’AGTCATTACAAATCT TGCCC-3’
Linear regression analysis for Scatchard plots
T h ed a t aw e r ea n a l y s e da c c o r d i n gt oS c a t c h a r d[ 2 3 ] .
The specific binding was determined by subtracting
non-specific binding from the total. The binding para-
meters, maximal binding (Bmax)a n de q u i l i b r i u md i s s o -
ciation constant (Kd), were derived by linear regression
analysis by plotting the specific binding of the radioli-
gand on X-axis and bound/free on Y-axis. The maximal
binding is a measure of the total number of receptors
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constant is the measure of the affinity of the receptors
for the radioligand. Kd is inversely related to receptor
affinity.
Radial Maze Test
Radial maze behavioral testing was conducted under
normal room lighting and utilized an eight armed radial
maze elevated 100 cm from the floor. Each arm of the
maze (11.5 cm wide) extended 68.5 cm from an octa-
gonally shaped central platform (40 cm across). Black
Plexiglas walls (11.5 cm high) were present only for the
first 20 cm of each arm to prevent the rat crossing from
one to another without returning to the central plat-
form. Circular food wells (1.3 cm deep, 3.2 cm diameter)
were located 2.5 cm from the end of each arm. The
maze was centered in an enclosed room where lighting
and spatial cues (e.g., posters, door, and boxes)
remained constant throughout the course of the experi-
ment. Arms were baited by placing one raisin in each
food well.
Rats were placed on the maze 3 days prior to the start
of formal acquisition testing in order to habituate them
to the apparatus. On the first day of habituation, 4 food
pellets were scattered along the length of each arm. The
rats were then systematically confined to each arm for 1
min to ensure their exposure to the entire maze. On the
second day of habituation, the previous day’s procedure
was repeated except that the animals were not confined
to each arm following 5 min of exploration. On the
third day, one food pellet was placed in the food well at
the end of each arm and a second was placed halfway
down each arm. Once the rats were habituated to the
maze, testing began. Trials began by placing a single rat
in the center of the maze facing away from the experi-
menter. The trial ended when the rat had obtained all 4
pellets or 5 min had elapsed, whichever occurred first.
Rats were run until they achieved criterion performance
for task acquisition. Criterion was attained when the rat
collected 3 out of the 4 food pellets within their first 4
arm entries within a trial (while still completing the
trial) with this level of performance being maintained
for 5 consecutive criterion performance. The number of
trials up to and including the last of these 5 criterion
performance formed the “number of trials to criterion”
measure. Experimental subjects were tested under blind
conditions. The time of testing was consistent from day
to day for each subject but testing of the various treat-
ment groups was distributed randomly throughout the
day.
Y-Maze Test
The Y-maze was made of grey wood, covered with black
paper, and consisted of three arms with an angle of 120°
between each of the arms. Each arm was 8 cm width
×30 cm length ×15 cm height. The three identical arms
were randomly designated: Start arm, in which the
mouse started to explore (always open); Novel arm,
which was blocked at the 1st trial, but open at the 2nd
trial; and the other arm (always open). The maze was
placed in a separate room with enough light. The floor
of the maze was covered with sawdust, which was
mixed after each individual trial in order to eliminate
olfactory stimuli. Visual cues were placed on the walls
of the maze.
The Y-maze test consisted of two trials separated by
an inter-trial interval (ITI). The first trial (training) was
10 min duration and allowed the mouse to explore only
two arms (start arm and the other arm) of the maze,
with the third arm (novel arm) blocked. After a 1 h ITI
[24], the second trial (retention) was conducted, during
which all three arms were accessible and novelty vs.
familiarity was analyzed through comparing behavior in
all three arms. For the second trial, the mouse was
placed back in the maze in the same starting arm, with
free access to all three arms for 5 min. The time spent
in each arm were analyzed data were expressed as per-
centage of performance in all three arms during the 5-
minutes of test [25].
Confocal imaging
Control and experimental rats were deeply anesthetized
with ether. The rat was transcardially perfused with PBS
(pH- 7.4) followed by 4% paraformaldehyde in PBS [26].
After perfusion the brains were dissected and immersion
fixed in 4% paraformaldehyde for 1 hr and then equili-
brated with 30% sucrose solution in 0.1 M PBS. 40 μm
sections were cut using Cryostat (Leica, CM1510 S).
The sections were treated with PBST (PBS in 0.05% Tri-
ton X-100) for 20 min. Brain slices were incubated over-
night at 4°C with rat primary antibody for GABAAa1.
The brain slices were then rinsed with PBST and then
incubated with Rhodamine coated secondary antibody.
The sections were observed and photographed using
confocal imaging system (Leica SP 5).
Results
Scatchard analysis of [
3H]GABA binding against GABA in
the cerebral cortex of Control, Epileptic, Epileptic +
Bacopa monnieri, Epileptic + Bacoside A, and Epileptic +
Carbamazepine treated rats
Scatchard analysis of [
3H]GABA against GABA in the
cerebral cortex showed a significant decrease (P < 0.001)
in the Bmax of epileptic rats compared to controls. Kd
showed significant decrease (P < 0.05) in the epileptic
group compared to control. Treatment using Bacopa
monnieri, Bacocide-A and Carbamazepine reversed the
Bmax to near control (Table 1).
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3H]bicuculline against Bicuculline
and [
3H]baclofen against baclofen in the cerebral cortex
of Control, Epileptic, Epileptic + Bacopa monnieri,
Epileptic + Bacoside A and Epileptic + Carbamazepine,
treated rats
Scatchard analysis of [
3H]bicuculline against bicuculline
and [
3H]baclofen against baclofen in the cerebral cortex
showed a significant decrease (P < 0.001) in the Bmax of
epileptic rats compared to controls. Kd showed signifi-
cant decrease (P < 0.05) in epileptic group compared to
control. Treatment using Bacopa monnieri, Bacocide-A
and Carbamazepine reversed the Bmax to near control
(Tables 2 and 3).
Real Time-PCR analysis of GABAAά1, GABAAά5 GABAAg and
GABAAδ, receptor subunit mRNA in the cerebral cortex of
Control, Epileptic, Epileptic + Bacopa monnier , Epileptic +
Bacoside A and Epileptic + Carbamazepine treated rats
Gene expression of GABAAά1,G A B A Ag and GABAAδ,
where showed significant down regulation (p < 0.001) in
the cerebral cortex of the epileptic rats compared to the
control. Gene expression of GABAAά5 receptor subunit
showed significant up regulation compared to the con-
trol. Treatment using Bacopa monnieri,B a c o c i d e - Aa n d
Carbamazepine reversed the changes to near control
(Figures 1, 2, 3 and 4).
Real Time-PCR analysis of GABAB, GAD65 and CREB
mRNA in the cerebral cortex of Control, Epileptic,
Epileptic + Bacopa monnieri, Epileptic + Bacoside A and
Epileptic + Carbamazepine treated Epileptic rats
Gene expression of CREB mRNA showed significant up
regulation (p < 0.001) in the cerebral cortex of the epi-
leptic rats compared to the control. GABAB,a n d
GAD65 mRNA were significantly down regulated com-
pared to the control. Treatment using Bacopa monnieri,
Bacoside-A and Carbamazepine were reversed the
changes to near control (Figures 5, 6 and 7).
Eight-Arm Radial Maze Performance
There was significant increase (p < 0.001) in the number
of trials required to achieve five consecutive criterion
performances in the epileptic rats compared to control.
Treatment using Bacopa monnieri and Bacoside-A
reversed this change to near control (Figure 8).
Y-Maze Performance
Time spent in the novel arm was decreed significantly
(p < 0.001) in the epileptic group compared to control.
Bacopa monnieri and Bacocide-A treated epileptic rats
were showed improved performance (Figure 9).
GABAAa1 receptor antibody staining in the Hippocampus
of Control, Epileptic, Epileptic + Bacopa monnieri,
Epileptic + Bacoside A and Epileptic + Carbamazepine
treated Epileptic rats
GABAAa1 receptor subunit antibody staining in the hip-
pocampus showed a significant decrease (p < 0.01) in
the GABAAa1 receptor subunit in epileptic rat compared
to control. Bacopa monnieri, Bacoside-A and Carbama-
zepine treated epileptic rats showed a significant reversal
(p < 0.05) of the decrease in GABAAa1 receptor subunit
staining in the hippocampus compared to epileptic rats
(Figure 10).
Table 1 Scatchard analysis of [3H]GABA binding against
GABA in the cerebral cortex of control and experimental
rats
Group Bmax (fmoles/mg ptn) Kd (nM)
C 112.3 ± 6.3 2.6 ± 0.3
E 44.0 ± 3.5*** 1.5 ± 0.1**
E+B 89.8 ± 5.6
@@ 2.3 ± 0.2
E+D 93.2 ± 4.7
@@ 2.2 ± 02
E+C 80.7 ± 5.2
@@ 2.1 ± 0.1
Values are mean ± SEM of 4-6 separate experiments. Each group consist of 6-
8 rats ** p < 0.01, *** p < 0.001 when compared to control, @@ < 0.01, @@@
< 0.001 when compared to epileptic group. C- Control, E- Epileptic, E+B-
Epileptic rats treated with Bacopa monnieri, E+D- Epileptic rats treated with
Bacoside A and E+C- Epileptic rats treated with Carbamazepine.
Table 2 Scatchard analysis of [
3H]bicuculline binding
against bicuculline in the cerebral cortex of control and
experimental rats
Group Bmax (fmoles/mg ptn) Kd (nM)
C 85.4 ± 4.5 1.7 ± 0.3
E 37.9 ± 3.9*** 0.9 ± 0.1**
E+B 75.0 ± 5.3
@@@ 1.2 ± 0.3
E+D 80.1 ± 6.1
@@@ 1.39 ± 0.1
E+C 76.5 ± 4.7
@@@ 1.38 ± 0.2
Values are mean ± SEM of 4-6 separate experiments. Each group consist of 6-
8 rats ** p < 0.01, *** p < 0.001 when compared to control, @@ < 0.01, @@@
< 0.001 when compared to epileptic group. C- Control, E- Epileptic, E+B-
Epileptic rats treated with Bacopa monnieri, E+D- Epileptic rats treated with
Bacoside A and E+C- Epileptic rats treated with Carbamazepine.
Table 3 Scatchard analysis of [
3H]baclofen binding
against Baclofen in the cerebral cortex of control and
experimental rats
Group Bmax (fmoles/mg ptn) Kd (nM)
C 124.3 ± 8.5 1.8 ± 0.2
E 91.9 ± 6.9*** 1.2 ± 0.1**
E+B 115.2 ± 7.3
@@@ 1.6 ± 0.3
E+D 111.7 ± 5.1
@@@ 1.3 ± 0.1
E+C 107.1 ± 7.7
@@@ 1.4 ± 0.2
Values are mean ± SEM of 4-6 separate experiments. Each group consist of 6-
8 rats ** p < 0.01, *** p < 0.001 when compared to control, @@ < 0.01, @@@
< 0.001 when compared to epileptic group. C- Control, E- Epileptic, E+B-
Epileptic rats treated with Bacopa monnieri, E+D- Epileptic rats treated with
Bacoside A and E+C- Epileptic rats treated with Carbamazepine.
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In this study, we focused on the involvement of cortical
GABA receptors in temporal lobe epilepsy, associated
mood disorders, spatial learning and memory deficit in
epileptic rats. TLE is a common end result of brain-
damaging insults with very different etiologies and initial
pathologies, such as genetic malformation, head trauma,
stroke, infection or status epilepticus [27]. Although
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Figure 1 Representative graph showing Real-Time amplification of GABA Aa1 receptor subunit mRNA from the Control and
experimental rats. The ΔΔCT method of relative quantification was used to determine the fold change in expression. Values are mean ± S.D of
4-6 separate experiments. C- Control, E- Epileptic, E+B- Epileptic + Bacopa monnieri, E+D- Epileptic + Bacoside-A, E+C- Epileptic + carbamazepine
treated rats. ***p < 0.001 when compared to control,
@@@p < 0.001 when compared to epileptic group.
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Figure 2 Representative graph showing Real-Time amplification of GABAAa5 receptor subunit mRNA from the Control and
experimental rats. The ΔΔCT method of relative quantification was used to determine the fold change in expression. Values are mean ± S.D of
4-6 separate experiments. C- Control, E- Epileptic, E+B- Epileptic + Bacopa monnieri, E+D- Epileptic + Bacoside-A, E+C- Epileptic + carbamazepine
treated rats. ***p < 0.001 when compared to control,
@@@p < 0.001 when compared to epileptic group.
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Figure 3 Representative graph showing Real-Time amplification of GABA Ag5 receptor subunit mRNA from the Control and
experimental rats. The ΔΔCT method of relative quantification was used to determine the fold change in expression. Values are mean ± S.D of
4-6 separate experiments. C- Control, E- Epileptic, E+B- Epileptic + Bacopa monnieri, E+D- Epileptic + Bacoside-A, E+C- Epileptic + carbamazepine
treated rats. ***p < 0.001 when compared to control,
@@@p < 0.001 when compared to epileptic group.
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Figure 4 Representative graph showing Real-Time amplification of GABA Aδ5 receptor subunit mRNA from the Control and
experimental rats. The ΔΔCT method of relative quantification was used to determine the fold change in expression. Values are mean ± S.D of
4-6 separate experiments. C- Control, E- Epileptic, E+B- Epileptic + Bacopa monnieri, E+D- Epileptic + Bacoside-A, E+C- Epileptic + carbamazepine
treated rats. ***p < 0.001 when compared to control,
@@@p < 0.001 when compared to epileptic group.
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Figure 5 Representative graph showing Real-Time amplification of GABAB receptor mRNA from the Control and experimental rats. The
ΔΔCT method of relative quantification was used to determine the fold change in expression. Values are mean ± S.D of 4-6 separate
experiments. C- Control, E- Epileptic, E+B- Epileptic + Bacopa monnieri, E+D- Epileptic + Bacoside-A, E+C- Epileptic + carbamazepine treated rats.
***p < 0.001 when compared to control,
@@@p < 0.001 when compared to epileptic group.
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Figure 6 Representative graph showing Real-Time amplification of GAD mRNA from the Control and experimental rats.T h eΔΔCT
method of relative quantification was used to determine the fold change in expression. Values are mean ± S.D of 4-6 separate experiments. C-
Control, E- Epileptic, E+B- Epileptic+ Bacopa monnieri, E+D- Epileptic + Bacoside-A, E+C- Epileptic + carbamazepine treated rats. ***p < 0.001
when compared to control,
@@@p < 0.001 when compared to epileptic group.
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Page 8 of 13there are various reports of the anticonvulsant and neu-
roprotective properties of Bacopa monnieri and its
active component Bacoside-A, little effort has been
extended to understand their pharmacological action on
the GABA receptors in the cerebral cortex of the
epileptic rats. GABA is the major inhibitory neurotrans-
mitter in the central nervous system [28,29]. It exerts an
inhibitory action in all forebrain structures and plays a
role in the physiopathogenesis of epilepsy [30]. GABAA
receptor binding influences the early portion of the
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Figure 7 Representative graph showing Real-Time amplification of CREB mRNA from the Control and experimental rats.T h eΔΔCT
method of relative quantification was used to determine the fold change in expression. Values are mean ± S.D of 4-6 separate experiments. C-
Control, E- Epileptic, E+B- Epileptic+ Bacopa monnieri, E+D- Epileptic + Bacoside-A, E+C- Epileptic + carbamazepine treated rats. ***p < 0.001
when compared to control,
@@p < 0.01,
@p < 0.05 when compared to epileptic group.
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Figure 8 Representative graph showing radial arm maze performance of control and experimental rats epileptic rats required more
daily trials to achieve three, four, and five consecutive criterion performances. Criterion performance was defined as consumption of the
bait in the four baited arms of the radial maze during no more than five entries. There was no significant difference in the average number of
trials required by kindled and control rats to achieve the initial criterion performance. C- Control, E- Epileptic, E+B- Epileptic + Bacopa monnieri,E
+D- Epileptic + Bacoside-A, E+C- Epileptic + carbamazepine treated rats.
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Page 9 of 13GABA mediated inhibitory postsynaptic potential,
whereas GABAB binding influences the late portion.
GABAA receptor activation in neurons induced a com-
plex physiological response, namely the activation of a
Cl
- conductance in concert with a blockade of the rest-
ing K
+ outward conductance results in hyperpolarisa-
tion. Both responses were mediated by the activation of
GABAA receptors, since they were both mimicked by
the GABAA receptor agonist muscimol and antagonized
by picrotoxin and bicuculline [2]. Reductions of GABA
mediated inhibition and decreased activity of GAD has
been reported in studies of human epileptic brain tissue.
Impairment of GABA functions produces seizures,
whereas enhancement results in an anticonvulsant effect
[31,32]. Support for a chronic loss of GABAergic func-
tion in epileptogenic human cortex has been based on
biochemical assays of tissue resected for relief of focal
seizure [33,34]. It is reported that in both epileptic and
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Figure 9 Representative graph showing Y maze performance of control and experimental rats. Epileptic rats showed less exploratory
behavior compared to control. C- Control, E- Epileptic, E+B- Epileptic + Bacopa monnieri, E+D- Epileptic + Bacoside-A, E+C- Epileptic +
carbamazepine treated rats. **p < 0.01 when compared to control,
@@p < 0.01 and
@p < 0.05 when compared to epileptic group.
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Figure 10 GABAAa1 receptor subunit antibody staining in the cerebral cortex of Control. and experimental rats. C- Control, E- Epileptic, E
+B- Epileptic + Bacopa monnieri, E+D- Epileptic + Bacoside-A, E+C- Epileptic + carbamazepine treated rats. Pixel intensity of experimental rats
were C-103465 ± 3043, E- 76456 ± 1593**, E+B-95835
@@ ± 2935, E+D-90564 ± 2553
@@, E+C-87593 ± 1093
@@. () Indicating the GABAAa1 receptor
subunit. **p < 0.01 when compared to control,
@@p < 0.01 when compared to epileptic group.
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Page 10 of 13histologically damaged cortex, there are significant
decreases in GAD and GABA binding [33]. We observed
a significant decrease in the Bmax of GABA receptors in
the cerebral cortex of epileptic rats compared to control
GABA receptors and GAD gene expression patterns
were similar to the receptor binding studies. Treatment
with Bacopa monnieri and Bacoside-A reversed the
receptor alterations in Bmax and gene expression to near
control. Previous studies from our lab showed that
Bacopa monnieri treatment to epileptic rats reduced the
number of seizures per hour which is suggestive of its
anticonvulsant property [35]. GAD plays a very impor-
tant role in maintaining excitatory inhibitory balance of
the central nervous system [36]. Analysis of GAD activ-
ity was used as a marker of over all GABAergic activity
and was found to be lower in epileptic mice. The enzy-
matic activity of GAD is the rate limiting step in the
production of GABA and GAD serve as a marker of
inhibitory neurons. Moreover, preliminary findings indi-
cate that the decrease in GABA is associated with
reduced GABA synthesis rather than increased degrada-
tion [37]. In order to provide a direct anatomic analysis
of GABAergic neurons and terminals in experimental
epilepsy, it is demonstrated a significant decrease in
immunocytochemically labeled GAD-positive neurons
and puncta in and adjacent to an alumina-damaged epi-
leptic focus in monkey motor cortex [38-40].
There are seizure-dependent increases in CRE-binding
activities in various brain regions of the mice [41]. Our
study showed that CREB mRNA was significantly
decreasing in the cerebral cortex of the epileptic rats.
Increased expression of total CREB and phosphorelated
CREB found in the human epileptic hippocampus. This
when considered with the observation that CREB med-
iate transcription from the GABAB Receptor1b
(GABABR1b) and GABABR1b promoters [42]; epileptic
rats exhibit elevated levels of GABA B Receptor 2
(GABABRs) subunit mRNAs and GABABRs antagonist
inhibit CREB-DNA binding activity at dose that inhibit
seizure behaviour, point to a novel feed back mechanism
to GABAB receptor in the generation and propagation
of seizure.
The incidence of psychiatric diseases in epileptics is
significantly higher than in the general population
[43-46]. Depressive and anxiety disorders are the most
common psychiatric diseases in this patient group.
Recent studies employing magnetic resonance spectro-
scopy (MRS) suggest that unipolar depression is asso-
ciated with reductions in cortical GABA levels [47,48].
Antidepressant and mood-stabilizing treatments also
appear to raise cortical GABA levels and to ameliorate
GABA deficits in patients with mood disorders [49].
Anxiety disorders have long been associated with distur-
bances of GABA function because of the ability of the
benzodiazepine anxiolytics to facilitate brain GABA neu-
rotransmission [50]. Interestingly, as with plasma studies
MRS also reveals lowered concentrations of GABA in
occipital cortex in panic disorder [51] and in subjects
with alcohol dependence [52]. We used two validated
psychopharmacological method Y-maze test to quantify
depression-like and anxiety-like behavior induced by the
decreased GABA receptors in the cerebral cortex of the
epileptic rats. Our study showed decreased exploratory
behaviour in epileptic rats and treatment using Bacopa
monnieri and bacoside-A brings back the exploratory
behaviour to near control. This can be correlated with
the decreased GABA receptors in the cerebral cortex of
the epileptic rat interactiont h r o u g h5 - H Tp a t h w a y s .
Immobility in rats is considered to be a state of lowed
mood or hopelessness which the rodent experience
when they are forced to explores in a constrained space
from they cannot escape. There are multiple interactions
between central GABA and 5-HT pathways, and some
of these interactions provide a theoretical framework in
which changes in cortical GABA function can lead to
some aspects of disrupted 5-HT function seen in
depressed patients [53,54]. In addition, interactions
between 5-HT and GABA offer a route by which 5-HT
targeted treatments might alter GABA function to bring
about their therapeutic effect [55]. Nigel et al., [56] have
suggested shared neurobiological processes leading both
to seizures and to behavioral, emotional and cognitive
d i s t u r b a n c ew h i c hc o u l dp o s s i b l ye x p l a i nt h eh o w
Bacopa monnieri is effective as an anti-convulsant and
an anti-depressant. Carbamzepine treatment to epileptic
rats also showed a similar effect.
Cerebral cortex plays a key role in memory, attention,
perceptual awareness, thought, language, mood and con-
sciousness. Epileptic patients are often suffering from
memory and cognitive problems [57-59]. Preliminary
studies established that the treatment with crude extract
and with the alcoholic extract of Bacopa monnieri plant
[60] enhanced learning ability in rats. The radial arm
maze experiment was conducted to study the neurobio-
logical mechanisms that underlie spatial learning and
memory functions in experimental. Radial arm maze is a
tool to examine the neural systems that are involved in
memory, and the influence of pharmacological com-
pounds on memory [61]. Radial arm maze experiment
demonstrated the impairment in spatial learning and
memory in the model studied. The administration of a
crude extract of Bacopa monnieri to epileptic rats
decreased the trial to attain the criterion performance in
the radial arm maze to control levels. These results con-
firmed the memory enhancing property of Bacopa mon-
nieri in epileptic rats. It is also reported to facilitate the
acquisition, consolidation, retention and recall of learned
tasks [62] and improve the speed at which visual
Mathew et al. Journal of Biomedical Science 2012, 19:25
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Page 11 of 13information is processed. Bacopa monnieri extracts and
isolated bacosides have been extensively investigated in
several studies for their neuropharmacological effects
and a number of reports are available confirming their
neuroprotective action [35].
Conclusion
Our experimental results support that decreased GABA
receptors and GAD activity in the cerebral cortex com-
prise an important role in seizure initiation and mood
disorders associated with epilepsy. We conclude from
our studies that Bacopa monnieri and Bacoside-A treat-
ment potentiates a therapeutic effect by reversing the
alterations in general GABA, GABAA,G A B A B receptor
binding, GABAA receptor subunits, GAD and CREB
gene expression that occur during epilepsy, resulting an
increased GABA mediated inhibition in the over stimu-
lated cerebral cortex neurons. Bacopa monnieri and
Bacoside-A treatment also useful for managing the
memory problems and mood disorders associated with
the epilepsy. This studies showed the therapeutic signifi-
cance of Bacopa monnieri, and its active component
Bacocide-A in the management of epilepsy, associated
mood disorders and memory problems.
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